Lodato, M.; Plaisance, V.; Pawlowski, V.; Kwapich, M.; Barras, A.; Buissart, E.; Dalle, S.; Szunerits, S.; Vicogne, J.; Boukherroub, R.;
et al. Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes? Cells 2023, 12, 940.
https://doi.org/10.3390/cells12060940
AMA Style
Lodato M, Plaisance V, Pawlowski V, Kwapich M, Barras A, Buissart E, Dalle S, Szunerits S, Vicogne J, Boukherroub R,
et al. Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes? Cells. 2023; 12(6):940.
https://doi.org/10.3390/cells12060940
Chicago/Turabian Style
Lodato, Michele, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, Emeline Buissart, Stéphane Dalle, Sabine Szunerits, Jérôme Vicogne, Rabah Boukherroub,
and et al. 2023. "Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?" Cells 12, no. 6: 940.
https://doi.org/10.3390/cells12060940
APA Style
Lodato, M., Plaisance, V., Pawlowski, V., Kwapich, M., Barras, A., Buissart, E., Dalle, S., Szunerits, S., Vicogne, J., Boukherroub, R., & Abderrahmani, A.
(2023). Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes? Cells, 12(6), 940.
https://doi.org/10.3390/cells12060940
